Despite our data suggesting that reduced Sox9 function promotes matrix mineralization via relieved repression of Spp1, Osteopontin and Sox9 are both highly expressed in human valves excised from patients with end-stage calcific aortic valve disease [25], [33], [34], [35], [36], [37], [38]. The gene discussed is SPP1; the disease is aortic valve calcification.